A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of addiction from narcotics treatments, a breakthrough which could provide hope for ...

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

Nerve or neuropathic pain has long been a tricky condition to treat effectively. However, a new study has comprehensively evaluated current drug and non-drug therapies to provide up-to-date guidelines ...

The algorithm also addresses pharmacologic approaches for debilitating and nondebilitating breast pain. 15-22 A short course of a scheduled oral nonsteroidal anti-inflammatory medication can improve ...